Trial · NCT02257567
Participant flow44
How many started, completed or left each group, period by period.
21 to 40 of 44
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | Safety Population | Arm F (Phase II Expansion): Pola+BG in DLBCL | 20 | |
| Overall Study | Safety Population | Arm G+H (Phase II NF Cohort): Pola+BR in DLBCL | 106 | |
| Overall Study | COMPLETED | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in FL | 4 | |
| Overall Study | COMPLETED | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in DLBCL | 4 | |
| Overall Study | COMPLETED | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in FL | 2 | |
| Overall Study | COMPLETED | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in DLBCL | 1 | |
| Overall Study | COMPLETED | Arm A (Phase II Randomization): Pola+BR in FL | 20 | |
| Overall Study | COMPLETED | Arm B (Phase II Randomization): BR in FL | 22 | |
| Overall Study | COMPLETED | Arm C (Phase II Randomization): Pola+BR in DLBCL | 6 | |
| Overall Study | COMPLETED | Arm D (Phase II Randomization): BR in DLBCL | 2 | |
| Overall Study | COMPLETED | Arm E (Phase II Expansion): Pola+BG in FL | 16 | |
| Overall Study | COMPLETED | Arm F (Phase II Expansion): Pola+BG in DLBCL | 0 | |
| Overall Study | COMPLETED | Arm G+H (Phase II NF Cohort): Pola+BR in DLBCL | 30 | |
| Overall Study | NOT COMPLETED | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in FL | 2 | |
| Overall Study | NOT COMPLETED | Cohort 1a (Phase Ib Safety Run-In): Pola+BR in DLBCL | 2 | |
| Overall Study | NOT COMPLETED | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in FL | 4 | |
| Overall Study | NOT COMPLETED | Cohort 1b (Phase Ib Safety Run-In): Pola+BG in DLBCL | 5 | |
| Overall Study | NOT COMPLETED | Arm A (Phase II Randomization): Pola+BR in FL | 19 | |
| Overall Study | NOT COMPLETED | Arm B (Phase II Randomization): BR in FL | 19 | |
| Overall Study | NOT COMPLETED | Arm C (Phase II Randomization): Pola+BR in DLBCL | 34 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02257567/flow?page=2